Complementary Therapy Use in with Diabetes Individuals and Information Source

Abstract

Amaç: Bu çalışmada diyabetli bireylerin kullandığı tamamlayıcı tedaviler ve bilgi kaynaklarının belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Kesitsel tipte gerçekleştirilen çalışmada 175 diyabetli birey dahil edildi. Verilerin elde edilmesinde katılımcıların sosyodemografik, diyabet ve tamamlayıcı tedavi kullanımlarına ilişkin özellikleri belirlemeye yönelik soru formu ile Tamamlayıcı ve Alternatif Tıp Yaklaşımları ölçeği kullanıldı. Bulgular: Diyabetli bireylerin %62.3’ü tamamlayıcı tedavi kullanmakta ve %59.6’sı bu tedavileri aile/akraba/arkadaş/komşularından öğrenmiştir. Katılımcıların %76.1’i kullandığı tedaviyi yararlı bulduğunu, %13.8’i yan etki yaşadığını, %92.7’si medikal tedavi ile etkileşiminin olup olmadığını bilmediğini, %83.5’i kullandığı tedavi hakkında hemşire ya da doktora bilgi vermediğini belirtmiştir. Sonuç: Diyabetli bireylerin büyük çoğunluğu tamamlayıcı tedavileri kullanmakta ancak bu tedaviler hakkında sağlık profesyonellerine bilgi vermemektedir. Kullanılan tamamlayıcı tedavilerden en fazla bitkisel ürünler kullanılmaktadır.

Keywords

• Diabetes
• Complementary Therapy
• Information Source
• Nursing

References

1. AHRQ. (2002). People who have diabetes are twice as likely to use complementary and alternative medicine as other patients, Research Activities Online Newsletter. Agency for Healthcare Research and Quality, 262: 2-28.
2. Arıkan, F., Artuk Uçar, MA. et al. (2019). Reasons for complementary therapy use by cancer patients, information sources and communication with health professionals. Complementary Therapies in Medicine, 44: 157-161. https://dx.doi.org/10.1016/j.ctim.2019.03.017.
3. Can, G., Erol, Ö., Aydıner, A. et al. (2009). Quality of life and complementary and alternative medicine use among cancer patients in Turkey. European Journal of Oncology Nursing. 13: 287–294. https://dx.doi.org/0.1016/j.ejon.2009.03.007
4. Chang, H., Wallis, M., Tiralongo, E. (2012). Predictors of complementary and alternative medicine use by people with type 2 diabetes. JAN, 68(6): 1256–66. https://doi.org/10.1111/j.1365-2648.2011.05827.x
5. Çalık A, Kapucu S. Diyabet tedavisinde kullanılan tamamlayıcı ve alternatif tedaviler: literatür derlemesi. Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. 2017;1(2): 79-84.
6. Dağtaş, Gülgün, PC., Kaya, H. (2015). Complementary and Alternative Medicine Use in Lung Cancer Patients and its Impact on the Quality of Life, Kafkas Journal of Medical Sciences, 5(2): 41–7. https://dx.doi.org/10.5505/kjms.2015.59454.
7. Damnjanovic, I., Kitic, D., Stefanovic, N. et al. (2015). Herbal self-medication use in patients with diabetes mellitus type 2. Turkish Journal of Medical Sciences, 45(4): 964-971. https://dx.doi.org/10.3906/sag-1507-97.
8. Dehghan, M., Ghaedi Heidari, F., Malakoutikhah, A. (2019). Complementary and alternative medicine usage and its determinant factors among Iranian patients with cancer. World Cancer Res J, 6:(1382): 1-8. https://dx.doi.org/10.32113/wcrj_20199_1382.

9. Egede, LE., Ye, X., Zheng, D. (2002). The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care, 25(2): 324–329. https://doi.org/10.2337/diacare.25.2.324
10. Fowler S., Newton L. (2006). Complementary and alternative the¬rapies: The nurse’s role. Journal of Neuroscience Nursing, 38: 1-4. https://dx.doi.org/10.1097/01376517-200608000-00009
11. Ilhan, M., Demir, B., Yüksel, S., et al. (2016). The use of complementary medicine in patients with diabetes. Northern Clinics of Istanbul, 3(1):34. https://dx.doi.org/10.14744/nci.2016.63825
12. International Diabetes Federation. Advocacy guide to the IDF Diabetes atlas ninth edition 2019. https://diabetesatlas.org/upload/resources/material/20191217_165723_2019_IDF_Advocacy_guide.pdf Erişim Tarihi: 15.05.2020.
13. Kaynak, İ., Polat, Ü. (2017). Diabetes mellitus' lu hastaların tamamlayıcı ve alternatif tedavileri kullanma durumları ve diyabet tutumları ile ilişkisi. Genel Tıp Dergisi, 27(2): 56-64.
14. Küçükgüçlü, Ö., Kızılcı, S., Mert, H. et al. (2012). Complementary and alternative medicine use among people with diabetes in Turkey. Western Journal of Nursing Research, 34: 902-16. https://doi.org/10.1177/0193945910387165.
15. Manya, K., Champion, B., Dunning, T. (2012). The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complementary and Alternative Medicine, 12(1): 2-5. https://dx.doi.org/10.1186/1472-6882-12-2.
16. Perez, H., Palacio, L., Fajardo, E. (2012). Complementary and alter¬native medicine: a new professional arena for clinical nurse specialists and health educators. Salud Uninorte. Barranqu¬illa, 28: 162-70.
17. Pumthong, G., Nathason, A., Tuseewan, M. et al. (2015). Complementary and alternative medicines for diabetes mellitus management in ASEAN countries. Complementary Therapies in Medicine, 23(4): 617-25. https://dx.doi.org/10.1016/j.ctim.2015.01.016.
18. Raja, R., Kumar, V., Khan, AA. et al. (2019). Knowledge, attitude, and practices of complementary and alternative medication usage in patients of Type II diabetes mellitus. Cureus, 11(8):53-7. https://dx.doi.org/10.7759/cureus.5357.
19. Satman, I., Omer, B., Tütüncü, Y., Kalaca, S. et. al. (2013). Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol, 28(2): 169-80. https://dx.doi.org/10.1007/s10654-013-9771-5.
20. Satman, I., Yilmaz, T., Sengül, A. et al. (2002). Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care, 25(9): 1551-6. https://doi.org/10.2337/diacare.25.9.1551.
21. Selçuk Tosun, A., Zincir, H., Eliş, E. (2019). Complementary and alternative medicine and self-efficacy level in Turkish adults with type 2 diabetes mellitus. Cukurova Medical Journal, 44(2): 309-18.
22. Shelley, BM., Sussman, AL., Williams, RL. Et al. (2009). ‘They don’t ask me so I don’t tell them’: Patient-clinician communication about traditional, complementary, and alternative medicine. The Annals of Family Medicine, 7(2): 139-47. https://dx.doi.org/10.1370/afm.947.
23. Shorofi, SA., Arbon, P. (2017). Complementary and alternative medicine (CAM) among Australian hospital-based nurses: knowledge, attitude, personal and professional use, Reasons for Use, CAM Referrals, and Socio-Demographic Predictors of CAM Users. Complement Ther Clin Pract, 27: 37-45. https://dx.doi.org/10.1016/j.ctcp.2017.03.001.
24. Şahin, OGA., Dirgar, AGE., Olgun, N. (2019). Diyabet yönetiminde kullanılan tamamlayıcı ve alternatif tedaviler. Diyabet, Obezite ve Hipertansiyonda Hemşirelik Forumu, 11(1): 32-6.
25. Tan, AC., Mak, J. (2015). Complementary and alternative medicine in diabetes (CALMIND)–a prospective study. Journal of Complementary and Integrative Medicine, 12(1): 95-9. https://dx.doi.org/10.1515/jcim-2014-0038.
26. Wanchai, A., Phrompayak D. (2016). Use of complementary and alternative medicine among Thai patients with type 2 diabetes mellitus. J Integr Med, 14(4): 297–305. https://dx.doi.org/10.1016/S2095-4964(16)60263-7.
27. Yukawa, K., Ishikawa, H., Yamazaki, Y. et al. (2017). Patient health literacy and patient-physician communication regarding complementary and alternative medicine usage. European Journal of Integrative Medicine, 10:38-45. https://doi.org/10.1016/j.eujim.2017.02.003.